Global Proton Therapy

Proton Therapy Comprehensive Study by Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, Beta Particle Beam), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Pediatric Conditions, Others), Room Type (Single Room, Multi Room), Solution (Proton Therapy Equipment, Proton Therapy Services) Players and Region - Global Market Outlook to 2030

Proton Therapy Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 13.76%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Proton Therapy
Since the last couple of years, proton therapy market is witnessing significant business growth with respect to numerous advantages over conventional radiotherapy techniques and a number of driving forces such as the rising prevalence of cancer, growing healthcare infrastructure across the glove as well as increasing research and developments. Proton therapy which is also known as proton beam therapy (PBT) is the most advanced and precise form of radiation oncology and its primary application is cancer treatment. Furthermore, PBT is a non-invasive & painless treatment which doesn’t hamper the quality of life of patients and allows physicians to deliver full or higher treatment dosages.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Billion)
CAGR13.76%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.The Players having a strong hold in the market are Philips N.V., Carecapital Group, Varian Medical Systems, Inc., Optivus Proton Therapy, Inc., Hitachi, Ltd.. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Proton Therapy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Koninklijke Philips N.V. (Netherlands), Carecapital Group (United Kingdom), Varian Medical Systems, Inc. (United States), Optivus Proton Therapy, Inc. (United States), Hitachi, Ltd. (Japan), Mevion Medical Systems (United States), ProTom International, Inc. (United States), Mitsubishi Electric Corporation (Japan), Sumitomo Corporation (Japan) and ProNova Solutions, LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are IBA International (Belgium), Radiology Oncology Systems (United States) and SAH Global LLC (United States).

Segmentation Overview
AMA Research has segmented the market of Global Proton Therapy market by Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam and Beta Particle Beam), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Pediatric Conditions and Others) and Region.



On the basis of geography, the market of Proton Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Room Type, the sub-segment i.e. Single Room will boost the Proton Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Solution, the sub-segment i.e. Proton Therapy Equipment will boost the Proton Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Shrinking Size of Proton Systems and Growing Adoption of Pencil Beam Scanning in Proton Therapy

Market Growth Drivers:
Increasing Prevalence of Cancer Patients and Growing Awareness about Enhances Insurance Coverage Regulations

Challenges:
Complex Motion Management Leads to Increased Rigidity and Lack of Proton Therapy Facility Availability across the Globe

Restraints:
Robust Initial Investments for Proton Therapy System Establishment and Proton Therapy requires a Large Linear Accelerator

Opportunities:
Generates Minimal Damage to Surrounding Tissues and Fewer Long Term Risks and Capability of High Radiations due to Precise Delivery of Protons

Market Leaders and their expansionary development strategies
In September 2023, Elekta partnered with the University of Pittsburgh School of Medicine to establish a research and development center focused on next-generation proton therapy technologies. This collaboration aims to advance the field of proton therapy and improve treatment outcomes for patients.
In October 2023, The University of Pittsburgh Medical Center (UPMC) opened its second proton therapy center in Monroeville, Pennsylvania. This facility complements the existing center in Pittsburgh and expands UPMC's reach in the Northeast.
Several primary initiatives are taken by international organizations such as International Atomic Energy Agency (IAEA), World Health Organization WHO, Canadian Partnership for Quality Radiotherapy (CPQR), American Association of Physicists in Medicine (AAPM) and American Society for Radiation Oncology (ASTRO). Mobilization of public and professional opinion in USA has resulted in a congressional hearing and the introduction of the Consistency, Accuracy, Responsibility, and Excellence (CARE) Act in the US Congress.

Key Target Audience
Proton Therapy System Manufacturers, Proton Therapy System Distributors and Suppliers, Refurbished Medical Equipment Sellers, Government Regulatory Bodies, Radiation Oncology Industry Associations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Electron Beam
  • Proton Beam
  • Neutron Beam
  • Carbon Ion Beam
  • Alpha Particle Beam
  • Beta Particle Beam
By Application
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Pediatric Conditions
  • Others
By Room Type
  • Single Room
  • Multi Room

By Solution
  • Proton Therapy Equipment
  • Proton Therapy Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Cancer Patients
      • 3.2.2. Growing Awareness about Enhances Insurance Coverage Regulations
    • 3.3. Market Challenges
      • 3.3.1. Complex Motion Management Leads to Increased Rigidity
      • 3.3.2. Lack of Proton Therapy Facility Availability across the Globe
    • 3.4. Market Trends
      • 3.4.1. Shrinking Size of Proton Systems
      • 3.4.2. Growing Adoption of Pencil Beam Scanning in Proton Therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Proton Therapy, by Type, Application, Room Type, Solution and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Proton Therapy (Value)
      • 5.2.1. Global Proton Therapy by: Type (Value)
        • 5.2.1.1. Electron Beam
        • 5.2.1.2. Proton Beam
        • 5.2.1.3. Neutron Beam
        • 5.2.1.4. Carbon Ion Beam
        • 5.2.1.5. Alpha Particle Beam
        • 5.2.1.6. Beta Particle Beam
      • 5.2.2. Global Proton Therapy by: Application (Value)
        • 5.2.2.1. Prostate Cancer
        • 5.2.2.2. Breast Cancer
        • 5.2.2.3. Lung Cancer
        • 5.2.2.4. Pediatric Conditions
        • 5.2.2.5. Others
      • 5.2.3. Global Proton Therapy by: Room Type (Value)
        • 5.2.3.1. Single Room
        • 5.2.3.2. Multi Room
      • 5.2.4. Global Proton Therapy by: Solution (Value)
        • 5.2.4.1. Proton Therapy Equipment
        • 5.2.4.2. Proton Therapy Services
      • 5.2.5. Global Proton Therapy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Proton Therapy (Price)
      • 5.3.1. Global Proton Therapy by: Type (Price)
  • 6. Proton Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Koninklijke Philips N.V. (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Carecapital Group (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Varian Medical Systems, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Optivus Proton Therapy, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hitachi, Ltd. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mevion Medical Systems (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ProTom International, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mitsubishi Electric Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sumitomo Corporation (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ProNova Solutions, LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Proton Therapy Sale, by Type, Application, Room Type, Solution and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Proton Therapy (Value)
      • 7.2.1. Global Proton Therapy by: Type (Value)
        • 7.2.1.1. Electron Beam
        • 7.2.1.2. Proton Beam
        • 7.2.1.3. Neutron Beam
        • 7.2.1.4. Carbon Ion Beam
        • 7.2.1.5. Alpha Particle Beam
        • 7.2.1.6. Beta Particle Beam
      • 7.2.2. Global Proton Therapy by: Application (Value)
        • 7.2.2.1. Prostate Cancer
        • 7.2.2.2. Breast Cancer
        • 7.2.2.3. Lung Cancer
        • 7.2.2.4. Pediatric Conditions
        • 7.2.2.5. Others
      • 7.2.3. Global Proton Therapy by: Room Type (Value)
        • 7.2.3.1. Single Room
        • 7.2.3.2. Multi Room
      • 7.2.4. Global Proton Therapy by: Solution (Value)
        • 7.2.4.1. Proton Therapy Equipment
        • 7.2.4.2. Proton Therapy Services
      • 7.2.5. Global Proton Therapy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Proton Therapy (Price)
      • 7.3.1. Global Proton Therapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Proton Therapy: by Type(USD Billion)
  • Table 2. Proton Therapy Electron Beam , by Region USD Billion (2018-2023)
  • Table 3. Proton Therapy Proton Beam , by Region USD Billion (2018-2023)
  • Table 4. Proton Therapy Neutron Beam , by Region USD Billion (2018-2023)
  • Table 5. Proton Therapy Carbon Ion Beam , by Region USD Billion (2018-2023)
  • Table 6. Proton Therapy Alpha Particle Beam , by Region USD Billion (2018-2023)
  • Table 7. Proton Therapy Beta Particle Beam , by Region USD Billion (2018-2023)
  • Table 8. Proton Therapy: by Application(USD Billion)
  • Table 9. Proton Therapy Prostate Cancer , by Region USD Billion (2018-2023)
  • Table 10. Proton Therapy Breast Cancer , by Region USD Billion (2018-2023)
  • Table 11. Proton Therapy Lung Cancer , by Region USD Billion (2018-2023)
  • Table 12. Proton Therapy Pediatric Conditions , by Region USD Billion (2018-2023)
  • Table 13. Proton Therapy Others , by Region USD Billion (2018-2023)
  • Table 14. Proton Therapy: by Room Type(USD Billion)
  • Table 15. Proton Therapy Single Room , by Region USD Billion (2018-2023)
  • Table 16. Proton Therapy Multi Room , by Region USD Billion (2018-2023)
  • Table 17. Proton Therapy: by Solution(USD Billion)
  • Table 18. Proton Therapy Proton Therapy Equipment , by Region USD Billion (2018-2023)
  • Table 19. Proton Therapy Proton Therapy Services , by Region USD Billion (2018-2023)
  • Table 20. South America Proton Therapy, by Country USD Billion (2018-2023)
  • Table 21. South America Proton Therapy, by Type USD Billion (2018-2023)
  • Table 22. South America Proton Therapy, by Application USD Billion (2018-2023)
  • Table 23. South America Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 24. South America Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 25. Brazil Proton Therapy, by Type USD Billion (2018-2023)
  • Table 26. Brazil Proton Therapy, by Application USD Billion (2018-2023)
  • Table 27. Brazil Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 28. Brazil Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 29. Argentina Proton Therapy, by Type USD Billion (2018-2023)
  • Table 30. Argentina Proton Therapy, by Application USD Billion (2018-2023)
  • Table 31. Argentina Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 32. Argentina Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 33. Rest of South America Proton Therapy, by Type USD Billion (2018-2023)
  • Table 34. Rest of South America Proton Therapy, by Application USD Billion (2018-2023)
  • Table 35. Rest of South America Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 36. Rest of South America Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 37. Asia Pacific Proton Therapy, by Country USD Billion (2018-2023)
  • Table 38. Asia Pacific Proton Therapy, by Type USD Billion (2018-2023)
  • Table 39. Asia Pacific Proton Therapy, by Application USD Billion (2018-2023)
  • Table 40. Asia Pacific Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 41. Asia Pacific Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 42. China Proton Therapy, by Type USD Billion (2018-2023)
  • Table 43. China Proton Therapy, by Application USD Billion (2018-2023)
  • Table 44. China Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 45. China Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 46. Japan Proton Therapy, by Type USD Billion (2018-2023)
  • Table 47. Japan Proton Therapy, by Application USD Billion (2018-2023)
  • Table 48. Japan Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 49. Japan Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 50. India Proton Therapy, by Type USD Billion (2018-2023)
  • Table 51. India Proton Therapy, by Application USD Billion (2018-2023)
  • Table 52. India Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 53. India Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 54. South Korea Proton Therapy, by Type USD Billion (2018-2023)
  • Table 55. South Korea Proton Therapy, by Application USD Billion (2018-2023)
  • Table 56. South Korea Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 57. South Korea Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 58. Taiwan Proton Therapy, by Type USD Billion (2018-2023)
  • Table 59. Taiwan Proton Therapy, by Application USD Billion (2018-2023)
  • Table 60. Taiwan Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 61. Taiwan Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 62. Australia Proton Therapy, by Type USD Billion (2018-2023)
  • Table 63. Australia Proton Therapy, by Application USD Billion (2018-2023)
  • Table 64. Australia Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 65. Australia Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 66. Rest of Asia-Pacific Proton Therapy, by Type USD Billion (2018-2023)
  • Table 67. Rest of Asia-Pacific Proton Therapy, by Application USD Billion (2018-2023)
  • Table 68. Rest of Asia-Pacific Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 69. Rest of Asia-Pacific Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 70. Europe Proton Therapy, by Country USD Billion (2018-2023)
  • Table 71. Europe Proton Therapy, by Type USD Billion (2018-2023)
  • Table 72. Europe Proton Therapy, by Application USD Billion (2018-2023)
  • Table 73. Europe Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 74. Europe Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 75. Germany Proton Therapy, by Type USD Billion (2018-2023)
  • Table 76. Germany Proton Therapy, by Application USD Billion (2018-2023)
  • Table 77. Germany Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 78. Germany Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 79. France Proton Therapy, by Type USD Billion (2018-2023)
  • Table 80. France Proton Therapy, by Application USD Billion (2018-2023)
  • Table 81. France Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 82. France Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 83. Italy Proton Therapy, by Type USD Billion (2018-2023)
  • Table 84. Italy Proton Therapy, by Application USD Billion (2018-2023)
  • Table 85. Italy Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 86. Italy Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 87. United Kingdom Proton Therapy, by Type USD Billion (2018-2023)
  • Table 88. United Kingdom Proton Therapy, by Application USD Billion (2018-2023)
  • Table 89. United Kingdom Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 90. United Kingdom Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 91. Netherlands Proton Therapy, by Type USD Billion (2018-2023)
  • Table 92. Netherlands Proton Therapy, by Application USD Billion (2018-2023)
  • Table 93. Netherlands Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 94. Netherlands Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 95. Rest of Europe Proton Therapy, by Type USD Billion (2018-2023)
  • Table 96. Rest of Europe Proton Therapy, by Application USD Billion (2018-2023)
  • Table 97. Rest of Europe Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 98. Rest of Europe Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 99. MEA Proton Therapy, by Country USD Billion (2018-2023)
  • Table 100. MEA Proton Therapy, by Type USD Billion (2018-2023)
  • Table 101. MEA Proton Therapy, by Application USD Billion (2018-2023)
  • Table 102. MEA Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 103. MEA Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 104. Middle East Proton Therapy, by Type USD Billion (2018-2023)
  • Table 105. Middle East Proton Therapy, by Application USD Billion (2018-2023)
  • Table 106. Middle East Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 107. Middle East Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 108. Africa Proton Therapy, by Type USD Billion (2018-2023)
  • Table 109. Africa Proton Therapy, by Application USD Billion (2018-2023)
  • Table 110. Africa Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 111. Africa Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 112. North America Proton Therapy, by Country USD Billion (2018-2023)
  • Table 113. North America Proton Therapy, by Type USD Billion (2018-2023)
  • Table 114. North America Proton Therapy, by Application USD Billion (2018-2023)
  • Table 115. North America Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 116. North America Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 117. United States Proton Therapy, by Type USD Billion (2018-2023)
  • Table 118. United States Proton Therapy, by Application USD Billion (2018-2023)
  • Table 119. United States Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 120. United States Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 121. Canada Proton Therapy, by Type USD Billion (2018-2023)
  • Table 122. Canada Proton Therapy, by Application USD Billion (2018-2023)
  • Table 123. Canada Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 124. Canada Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 125. Mexico Proton Therapy, by Type USD Billion (2018-2023)
  • Table 126. Mexico Proton Therapy, by Application USD Billion (2018-2023)
  • Table 127. Mexico Proton Therapy, by Room Type USD Billion (2018-2023)
  • Table 128. Mexico Proton Therapy, by Solution USD Billion (2018-2023)
  • Table 129. Proton Therapy: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Proton Therapy: by Type(USD Billion)
  • Table 141. Proton Therapy Electron Beam , by Region USD Billion (2025-2030)
  • Table 142. Proton Therapy Proton Beam , by Region USD Billion (2025-2030)
  • Table 143. Proton Therapy Neutron Beam , by Region USD Billion (2025-2030)
  • Table 144. Proton Therapy Carbon Ion Beam , by Region USD Billion (2025-2030)
  • Table 145. Proton Therapy Alpha Particle Beam , by Region USD Billion (2025-2030)
  • Table 146. Proton Therapy Beta Particle Beam , by Region USD Billion (2025-2030)
  • Table 147. Proton Therapy: by Application(USD Billion)
  • Table 148. Proton Therapy Prostate Cancer , by Region USD Billion (2025-2030)
  • Table 149. Proton Therapy Breast Cancer , by Region USD Billion (2025-2030)
  • Table 150. Proton Therapy Lung Cancer , by Region USD Billion (2025-2030)
  • Table 151. Proton Therapy Pediatric Conditions , by Region USD Billion (2025-2030)
  • Table 152. Proton Therapy Others , by Region USD Billion (2025-2030)
  • Table 153. Proton Therapy: by Room Type(USD Billion)
  • Table 154. Proton Therapy Single Room , by Region USD Billion (2025-2030)
  • Table 155. Proton Therapy Multi Room , by Region USD Billion (2025-2030)
  • Table 156. Proton Therapy: by Solution(USD Billion)
  • Table 157. Proton Therapy Proton Therapy Equipment , by Region USD Billion (2025-2030)
  • Table 158. Proton Therapy Proton Therapy Services , by Region USD Billion (2025-2030)
  • Table 159. South America Proton Therapy, by Country USD Billion (2025-2030)
  • Table 160. South America Proton Therapy, by Type USD Billion (2025-2030)
  • Table 161. South America Proton Therapy, by Application USD Billion (2025-2030)
  • Table 162. South America Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 163. South America Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 164. Brazil Proton Therapy, by Type USD Billion (2025-2030)
  • Table 165. Brazil Proton Therapy, by Application USD Billion (2025-2030)
  • Table 166. Brazil Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 167. Brazil Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 168. Argentina Proton Therapy, by Type USD Billion (2025-2030)
  • Table 169. Argentina Proton Therapy, by Application USD Billion (2025-2030)
  • Table 170. Argentina Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 171. Argentina Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 172. Rest of South America Proton Therapy, by Type USD Billion (2025-2030)
  • Table 173. Rest of South America Proton Therapy, by Application USD Billion (2025-2030)
  • Table 174. Rest of South America Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 175. Rest of South America Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 176. Asia Pacific Proton Therapy, by Country USD Billion (2025-2030)
  • Table 177. Asia Pacific Proton Therapy, by Type USD Billion (2025-2030)
  • Table 178. Asia Pacific Proton Therapy, by Application USD Billion (2025-2030)
  • Table 179. Asia Pacific Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 180. Asia Pacific Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 181. China Proton Therapy, by Type USD Billion (2025-2030)
  • Table 182. China Proton Therapy, by Application USD Billion (2025-2030)
  • Table 183. China Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 184. China Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 185. Japan Proton Therapy, by Type USD Billion (2025-2030)
  • Table 186. Japan Proton Therapy, by Application USD Billion (2025-2030)
  • Table 187. Japan Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 188. Japan Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 189. India Proton Therapy, by Type USD Billion (2025-2030)
  • Table 190. India Proton Therapy, by Application USD Billion (2025-2030)
  • Table 191. India Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 192. India Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 193. South Korea Proton Therapy, by Type USD Billion (2025-2030)
  • Table 194. South Korea Proton Therapy, by Application USD Billion (2025-2030)
  • Table 195. South Korea Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 196. South Korea Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 197. Taiwan Proton Therapy, by Type USD Billion (2025-2030)
  • Table 198. Taiwan Proton Therapy, by Application USD Billion (2025-2030)
  • Table 199. Taiwan Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 200. Taiwan Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 201. Australia Proton Therapy, by Type USD Billion (2025-2030)
  • Table 202. Australia Proton Therapy, by Application USD Billion (2025-2030)
  • Table 203. Australia Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 204. Australia Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 205. Rest of Asia-Pacific Proton Therapy, by Type USD Billion (2025-2030)
  • Table 206. Rest of Asia-Pacific Proton Therapy, by Application USD Billion (2025-2030)
  • Table 207. Rest of Asia-Pacific Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 208. Rest of Asia-Pacific Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 209. Europe Proton Therapy, by Country USD Billion (2025-2030)
  • Table 210. Europe Proton Therapy, by Type USD Billion (2025-2030)
  • Table 211. Europe Proton Therapy, by Application USD Billion (2025-2030)
  • Table 212. Europe Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 213. Europe Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 214. Germany Proton Therapy, by Type USD Billion (2025-2030)
  • Table 215. Germany Proton Therapy, by Application USD Billion (2025-2030)
  • Table 216. Germany Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 217. Germany Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 218. France Proton Therapy, by Type USD Billion (2025-2030)
  • Table 219. France Proton Therapy, by Application USD Billion (2025-2030)
  • Table 220. France Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 221. France Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 222. Italy Proton Therapy, by Type USD Billion (2025-2030)
  • Table 223. Italy Proton Therapy, by Application USD Billion (2025-2030)
  • Table 224. Italy Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 225. Italy Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 226. United Kingdom Proton Therapy, by Type USD Billion (2025-2030)
  • Table 227. United Kingdom Proton Therapy, by Application USD Billion (2025-2030)
  • Table 228. United Kingdom Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 229. United Kingdom Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 230. Netherlands Proton Therapy, by Type USD Billion (2025-2030)
  • Table 231. Netherlands Proton Therapy, by Application USD Billion (2025-2030)
  • Table 232. Netherlands Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 233. Netherlands Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 234. Rest of Europe Proton Therapy, by Type USD Billion (2025-2030)
  • Table 235. Rest of Europe Proton Therapy, by Application USD Billion (2025-2030)
  • Table 236. Rest of Europe Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 237. Rest of Europe Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 238. MEA Proton Therapy, by Country USD Billion (2025-2030)
  • Table 239. MEA Proton Therapy, by Type USD Billion (2025-2030)
  • Table 240. MEA Proton Therapy, by Application USD Billion (2025-2030)
  • Table 241. MEA Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 242. MEA Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 243. Middle East Proton Therapy, by Type USD Billion (2025-2030)
  • Table 244. Middle East Proton Therapy, by Application USD Billion (2025-2030)
  • Table 245. Middle East Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 246. Middle East Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 247. Africa Proton Therapy, by Type USD Billion (2025-2030)
  • Table 248. Africa Proton Therapy, by Application USD Billion (2025-2030)
  • Table 249. Africa Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 250. Africa Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 251. North America Proton Therapy, by Country USD Billion (2025-2030)
  • Table 252. North America Proton Therapy, by Type USD Billion (2025-2030)
  • Table 253. North America Proton Therapy, by Application USD Billion (2025-2030)
  • Table 254. North America Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 255. North America Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 256. United States Proton Therapy, by Type USD Billion (2025-2030)
  • Table 257. United States Proton Therapy, by Application USD Billion (2025-2030)
  • Table 258. United States Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 259. United States Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 260. Canada Proton Therapy, by Type USD Billion (2025-2030)
  • Table 261. Canada Proton Therapy, by Application USD Billion (2025-2030)
  • Table 262. Canada Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 263. Canada Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 264. Mexico Proton Therapy, by Type USD Billion (2025-2030)
  • Table 265. Mexico Proton Therapy, by Application USD Billion (2025-2030)
  • Table 266. Mexico Proton Therapy, by Room Type USD Billion (2025-2030)
  • Table 267. Mexico Proton Therapy, by Solution USD Billion (2025-2030)
  • Table 268. Proton Therapy: by Type(USD/Units)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Proton Therapy: by Type USD Billion (2018-2023)
  • Figure 5. Global Proton Therapy: by Application USD Billion (2018-2023)
  • Figure 6. Global Proton Therapy: by Room Type USD Billion (2018-2023)
  • Figure 7. Global Proton Therapy: by Solution USD Billion (2018-2023)
  • Figure 8. South America Proton Therapy Share (%), by Country
  • Figure 9. Asia Pacific Proton Therapy Share (%), by Country
  • Figure 10. Europe Proton Therapy Share (%), by Country
  • Figure 11. MEA Proton Therapy Share (%), by Country
  • Figure 12. North America Proton Therapy Share (%), by Country
  • Figure 13. Global Proton Therapy: by Type USD/Units (2018-2023)
  • Figure 14. Global Proton Therapy share by Players 2023 (%)
  • Figure 15. Global Proton Therapy share by Players (Top 3) 2023(%)
  • Figure 16. Global Proton Therapy share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 19. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 20. Carecapital Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. Carecapital Group (United Kingdom) Revenue: by Geography 2023
  • Figure 22. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Optivus Proton Therapy, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Optivus Proton Therapy, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Hitachi, Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Hitachi, Ltd. (Japan) Revenue: by Geography 2023
  • Figure 28. Mevion Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 29. Mevion Medical Systems (United States) Revenue: by Geography 2023
  • Figure 30. ProTom International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. ProTom International, Inc. (United States) Revenue: by Geography 2023
  • Figure 32. Mitsubishi Electric Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Mitsubishi Electric Corporation (Japan) Revenue: by Geography 2023
  • Figure 34. Sumitomo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Sumitomo Corporation (Japan) Revenue: by Geography 2023
  • Figure 36. ProNova Solutions, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 37. ProNova Solutions, LLC (United States) Revenue: by Geography 2023
  • Figure 38. Global Proton Therapy: by Type USD Billion (2025-2030)
  • Figure 39. Global Proton Therapy: by Application USD Billion (2025-2030)
  • Figure 40. Global Proton Therapy: by Room Type USD Billion (2025-2030)
  • Figure 41. Global Proton Therapy: by Solution USD Billion (2025-2030)
  • Figure 42. South America Proton Therapy Share (%), by Country
  • Figure 43. Asia Pacific Proton Therapy Share (%), by Country
  • Figure 44. Europe Proton Therapy Share (%), by Country
  • Figure 45. MEA Proton Therapy Share (%), by Country
  • Figure 46. North America Proton Therapy Share (%), by Country
  • Figure 47. Global Proton Therapy: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Koninklijke Philips N.V. (Netherlands)
  • Carecapital Group (United Kingdom)
  • Varian Medical Systems, Inc. (United States)
  • Optivus Proton Therapy, Inc. (United States)
  • Hitachi, Ltd. (Japan)
  • Mevion Medical Systems (United States)
  • ProTom International, Inc. (United States)
  • Mitsubishi Electric Corporation (Japan)
  • Sumitomo Corporation (Japan)
  • ProNova Solutions, LLC (United States)
Additional players considered in the study are as follows:
IBA International (Belgium) , Radiology Oncology Systems (United States) , SAH Global LLC (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 210 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Proton Therapy Quantitative research analysis
Global Proton Therapy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Koninklijke Philips N.V. (Netherlands), Carecapital Group (United Kingdom), Varian Medical Systems, Inc. (United States), Optivus Proton Therapy, Inc. (United States), Hitachi, Ltd. (Japan), Mevion Medical Systems (United States), ProTom International, Inc. (United States), Mitsubishi Electric Corporation (Japan), Sumitomo Corporation (Japan) and ProNova Solutions, LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Shrinking Size of Proton Systems " is seen as one of major influencing trends for Proton Therapy Market during projected period 2023-2030.
The Proton Therapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Proton Therapy Report?

Have a Query? Click Here

Other Related Reports

Positron Emission tomography Comprehensive Study by Type (PET-CT, PET-MR, Other), Application (Cancer Treatment, Neurology, Cardiology), PET Scanner (Full Ring PET Scanners, Partial Ring PET Scanners...
$ 3650
Heart Rate Sensor Comprehensive Study by Type (Electrocardiography or electrical, Photoplethysmography or optical), Application (Smartwatch, ECG Monitor, Sportswear, Other), Sales channel (Direct sal...
$ 3800
High Throughput Process Development Comprehensive Study by Type (Consumables (Miniature Prepacked Columns, Micro-well Filter Plates, Miniature Disposable Bioreactor, Micropipettes and Pipette Tips), ...
$ 3750
Patient Engagement Solutions Comprehensive Study by Application (Health Management, Social and Behavioral Management, Home Health Management, Financial Health Management), End User (Providers, Payer...
$ 3750
Pest Control Products Comprehensive Study by Type (Powder, Sprays, Pellets, Traps, Baits), Application (Commercial, Residential, Industrial, Agricultural), Biological Control Product Type (Microbials...
$ 3750
Hair Loss Men and Women Comprehensive Study by Type (Hair Loss and Growth Devices, Shampoos and Conditioners, Medicine Product), Application (Male, Female), End Use (Dermatology clinics, Homecare set...
$ 3350